AAPG (AAPG) Earnings Call Analysis
Earnings Reports
-
AAPG Q4 2025: Dual Product Launch Drives 90% Revenue Surge, Global Trial Enrollment Sets 2027 NDA Path
March 26, 2026
-
AAPG Q1 2025: Dual-Engine Commercialization Drives 90% Revenue Growth, Global Trial Enrollment Accelerates
March 26, 2026
-
AAPG Q2 2025: Olverembatinib China Sales Surge 93% as Dual-Engine Strategy Accelerates Hematology Expansion
August 21, 2025